Skip to content

Outi Vaarala

Professor of Pediatric Immunology, Professor of Autoimmune Diseases, PhD in immunology b. 1962

Senior Vice President, Innovative Medicines and Research & Development as of 1 January 2023

Ownership of shares 31 Dec 2023: 7,098 Orion Corporation B shares

Career in Orion

2023- Senior Vice President, Innovative Medicines and Research & Development
2020-2022 Senior Vice President, Research and Development
2019-2020 Vice President of Oncology Research

Earlier career

2018-2019 Senior Director Research, Respiratory Inflammation and Autoimmunity,  Medimmune, AstraZeneca, The United States
2017-2018 Vice President, Head of Lung Immunity, AstraZeneca, Sweden
2014-2017 Vice President, Head of Translational Science, AstraZeneca, Sweden
2014 Director of the Department of Vaccinations and Immune Protection; Finnish Institute for Health and  Welfare (THL)
2005-2014 Research Professor, Head of the Immune Response Unit, Department of Vaccines and Immune Protection; Finnish Institute for Health and Welfare (THL)

Current key positions of trust

Member of the Board of Directors: Tampere University Foundation 2021-

Former key positions of trust

2005-2014 Permanent expert at the European Medicines Agency (EMA)


More than 200 peer-reviewed scientific articles in internationally renowned scientific journals (as in Science Translational Medicine, Cell Host Microbes, JAMA, New England Journal of Medicine, the Lancet, and Journal of Immunology).

Orion_OEMB_Outi-Vaarala.jpg

Member of the Executive Management Board

Outi Vaarala